Cadila Healthcare (also known as Zydus Cadila) said that it has adopted a new technology initiative called ‘Zydus Verify’ to protect patients against counterfeit drugs. In this connection, the Indian pharma company has rolled out a new feature in the packaging of its critical drugs for helping patients in identifying whether the product is genuine […]
Zydus Cadila has secured restricted emergency use approval for ‘Virafin’, Pegylated Interferon alpha-2b (PegIFN) from the Drug Controller General of India (DCGI) for the treatment of moderate Covid-19 infection in adult patients. According to the Indian pharma company, a single dose subcutaneous regimen of Virafin will make the treatment more easier for the patients. When […]